1. Home
  2. UL vs BSX Comparison

UL vs BSX Comparison

Compare UL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UL
  • BSX
  • Stock Information
  • Founded
  • UL 1930
  • BSX 1979
  • Country
  • UL United Kingdom
  • BSX United States
  • Employees
  • UL N/A
  • BSX N/A
  • Industry
  • UL Package Goods/Cosmetics
  • BSX Medical/Dental Instruments
  • Sector
  • UL Consumer Discretionary
  • BSX Health Care
  • Exchange
  • UL Nasdaq
  • BSX Nasdaq
  • Market Cap
  • UL 149.3B
  • BSX 157.6B
  • IPO Year
  • UL N/A
  • BSX 1992
  • Fundamental
  • Price
  • UL $63.50
  • BSX $104.36
  • Analyst Decision
  • UL Hold
  • BSX Strong Buy
  • Analyst Count
  • UL 1
  • BSX 22
  • Target Price
  • UL N/A
  • BSX $118.91
  • AVG Volume (30 Days)
  • UL 2.2M
  • BSX 6.5M
  • Earning Date
  • UL 07-31-2025
  • BSX 10-22-2025
  • Dividend Yield
  • UL 3.10%
  • BSX N/A
  • EPS Growth
  • UL N/A
  • BSX 36.90
  • EPS
  • UL 2.63
  • BSX 1.68
  • Revenue
  • UL $70,194,950,090.00
  • BSX $18,494,000,000.00
  • Revenue This Year
  • UL N/A
  • BSX $19.75
  • Revenue Next Year
  • UL $2.96
  • BSX $10.98
  • P/E Ratio
  • UL $24.18
  • BSX $62.10
  • Revenue Growth
  • UL N/A
  • BSX 21.44
  • 52 Week Low
  • UL $54.32
  • BSX $80.64
  • 52 Week High
  • UL $65.87
  • BSX $109.50
  • Technical
  • Relative Strength Index (RSI)
  • UL 55.86
  • BSX 44.46
  • Support Level
  • UL $62.60
  • BSX $104.24
  • Resistance Level
  • UL $65.01
  • BSX $109.50
  • Average True Range (ATR)
  • UL 0.64
  • BSX 1.85
  • MACD
  • UL -0.04
  • BSX -0.12
  • Stochastic Oscillator
  • UL 53.11
  • BSX 14.05

About UL Unilever PLC

Unilever is a diversified beauty, wellbeing, and personal care (44% of 2024 sales by value), homecare (20%), and packaged food (36%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: